Building on three years of generic adherence experience, Sempre brings its proven engagement model to the full medication portfolio of members already enrolled through their branded therapy
Sempre Health welcomes Dr. John M. O’Brien, a recognized leader in health policy and pharmaceutical innovation, to its Board of Directors.
New location-based savings alerts redefine the pharmacy visit and underscore Sempre Health’s ongoing commitment to medication adherence innovation
The Journal of the American College of Radiology features Sempre Health’s platform model that bridges pharma, health plans, and patients to improve medication access and adherence.
Sempre sat down with Michael Einodshofer whose deep experience in the pharmaceutical value chain gives him a unique perspective on the industry’s challenges. Read the full interview to learn more.
PR Newswire
PR Newswire